This resistance has been ascribed, at least in part, to tumour cell expression of the Multi-Drug Resistance gene (MDR1) encoding P-glycoprotein [138], and indeed the current chemotherapy regimen has been designed accordingly. Here, ABCB1 is linked to neoplasm.